MRE11 and breast cancer: Hu et al. analyzed 38,332 US breast cancer patients and identified 28 (0.07%) carriers of pathogenic germline variants in MRE11, 66 (0.17%) in NBN, and 72 (0.19%) in RAD50 but these frequencies did not differ from that in controls [91].